Leprosy (Hansen disease)

A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Publication

Treatment in leprosy with etisul preliminary information

Loginov V K, VANTANOVA N G, BRAGINA V S. Leprosy review. 1963;

Download PDF

Publication

[Prophylaxis of leprosy].

Contreras F. Revista de sanidad e higiene publica. 1953; 27 (3-4) : 226-48.

Publication

Classification by objectives: a rejoinder.

Thomas M J, Thomas M, Babu RG, et al. Leprosy review. 2003; 74 (2) : 175-6.

Download PDF

Publication

The cliffs of Kalaupapa.

Thomas E D. Wilderness & environmental medicine. 1995; 6 (3) : 346-7.

Publication

Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNFalpha production in vitro.

Sampaio E P, Hernandez M O, Carvalho D S, et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2002; 56 (1) : 13-9.

Publication

Thalidomide, a drug which may protect the organism against some aggressive effects of the immunologic system.

Mathé G. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2002; 56 (1) : 1-3.

Publication

Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells.

Rambukkana A, Zanazzi G, Tapinos N, et al. Science (New York, N.Y.). 2002; 296 (5569) : 927-31.

Publication

The psychosocial needs of leprosy patients.

Scott J. Leprosy review. 2000; 71 (4) : 486-91.

Download PDF

Publication

Dapsone and sulfapyridine.

Paniker U, Levine N. Dermatologic clinics. 2001; 19 (1) : 79-86, viii.

Publication

Leproma of the mouse foot.

Job C K, Chacko C J, Verghese R, et al. Leprosy review. 1975; 46 (1) : 39-49.

Download PDF

Subscribe to Leprosy (Hansen disease)